background
background
Dr. Joel Cherlow, MD

Dr. Joel Cherlow, MD

Radiation Oncology*
45+ years of experience

Dr. Joel Cherlow, MD is a radiation oncologist in Laguna Hills, CA and has over 45 years of experience in the medical field. He graduated from UNIVERSITY OF CALIFORNIA AT LOS ANGELES / CENTER FOR HEALTH SCIENCES in 1979. He is affiliated with medical facilities MemorialCare Saddleback Medical Center and MemorialCare Miller Children's & Women's Hospital Long Beach.

3.4 Star Rating
Based on 5 reviews 3.4 Star Rating (5 reviews)

Practice

24302 Paseo de Valencia Laguna Hills, CA 92653

Make an Appointment

Hospital Highlight

Dr. Cherlow is affiliated with MemorialCare Saddleback Medical Center Laguna Hills, a highly rated hospital.

At a Glance

  • Area of Expertise
    Dr. Cherlow specializes in the area of Therapeutic Radiology. See board certifications
  • Friendly Staff
    Patients said the staff was friendly. See reviews
  • Practices at Top Hospital
    America's 250 Best Hospitals Award™ See hospitals
  • Hospital Satisfaction
    Patients said they were highly satisfied at this doctor's hospital. See hospitals
ADVERTISEMENT
healthgrades-rx

Save money with free prescription discounts

Optum Perks and Healthgrades are subsidiaries of RVO Health.

Experience Check

Search for experience in a specific area

Insurance Check

Search for your insurance carrier and choose your plan type

Dr. Cherlow's Reviews

Likelihood to recommend Dr. Cherlow

3.4

5 ratings, 3 with a written review
5 Star
60%
60%
4 Star
0%
0%
3 Star
0%
0%
2 Star
0%
0%
1 Star
40%
40%

Your trust is our top concern. Learn more.

We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.

All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.

Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.

Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.

RecentHighestLowestMost Helpful
What went well
  • Appointment scheduling
  • Listened & answered questions
  • Explained conditions well
  • Staff friendliness
  • Appointment wasn't rushed
  • Trusted the provider's decisions
  • Wait times
What could be improved
No results
Helpful
May 05, 2018
×Post a ResponseAre you Dr. Joel Cherlow, MD?
What went well
  • Staff friendliness
  • Wait times
What could be improved
  • Didn't listen or answer questions
  • Didn't explain conditions well
  • Appointment was rushed
  • Didn't trust the provider's decisions
1 person found this helpful
Helpful
Mission Viejo, CA – Mar 29, 2017
×Post a ResponseAre you Dr. Joel Cherlow, MD?
What went well
No results
What could be improved
  • Difficult to schedule appointment
  • Didn't listen or answer questions
  • Didn't explain conditions well
  • Staff wasn't friendly
  • Didn't trust the provider's decisions
  • Long wait times
3 people found this helpful
Helpful
Lake Forest, CA – Jan 27, 2017
×Post a ResponseAre you Dr. Joel Cherlow, MD?

Leave a review

How was your experience with Dr. Cherlow?

About Me

biography

Dr. Joel Cherlow, MD is a radiation oncologist in Laguna Hills, CA and has over 45 years of experience in the medical field. He graduated from UNIVERSITY OF CALIFORNIA AT LOS ANGELES / CENTER FOR HEALTH SCIENCES in 1979. He is affiliated with medical...read more
  • Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

  • University Of California At Los Angeles / Center For Health Sciences

    Medical School, 1979
American Board of Medical Specialties®
American Board of Radiology®
Therapeutic Radiology
For detailed information about any of the below board actions, please search for the provider's records on the linked state licensing board or the Federation of State Medical Boards. To learn more about the difference between these sources, please refer to our FAQs.
Healthgrades has not received any data indicating a board action exists for this provider.
  • Intrathecal methotrexate is sufficient central nervous system (CNS) prophylaxis for high risk patients with acute lymphoblastic leukemia (ALL) showing a rapid early response (RER) to BFM induction chemotherapy

  • Treatment of High Grade Spinal Cord Astrocytoma of Childhood with "8-in-1" Chemotherapy and Radiotherapy: A Pilot Study of CCG-945

  • Radiotherapy to extra-abdominal bulk disease and/or for central nervous system prophylaxis with intensive chemotherapy of acute lymphoblastic leukemia and lymphomatous presenting features

  • Radiation treatments or surgery in 33 cases of juvenile angiofibroma of the nasopharynx

  • Treatment of Patients with Acute Lymphoblastic Leukemia with Bulky Extramedullary Disease and T-Cell Phenotype or Other Poor Prognostic Features: Randomized Controlled Trial from the Children's Cancer Group

  • Children with acute lymphoblastic leukemia with lymphomatous features (ALL-LF) and normal marrow chromosomes have a better outcome than patients with abnormal chromosomes 9:219

  • Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy

  • High Dose Rate (HDR) Brachytherapy for Treatment of Primary Head and Neck Cancer.

  • Acute lymphoblastic leukemia (ALL) with lymphomatous features at diagnosis in children

  • Brachytherapy For Primary And Recurrent Nasopharyngeal Carcinoma: 20 Years Experience At Long Beach Memorial

  • The role of radiation therapy in the management of acute lymphoblastic leukemia with lymphomatous presentation (ALLILP)

  • Low-stage medulloblastoma: final analysis of trial comparing standard-dose reduced-dose neuraxis irradiation

  • Cranio-spinal radiation for CNS leukemia at presentation -- how high does the spinal dose need to be?

  • Predictive value of early response in intermediate risk acute lymphoblastic leukemia in children, Children's Cancer Group (CCG) 1891

  • Children's Cancer Group (CCG) study 1882: Augmented BFM (A-BFM) for treatment of children and young adults with high risk acute lymphoblastic leukemia (ALL) showing slow early response (SER)

  • Treatment of acute lymphoblastic leukemia with lymphomatous presenting features

  • "INDIRA" Trial: De Novo Low Dose Rate lntracoronary Irradiation After Angioplasty and Stent Placement for Prevention of Restenosis.

  • Early marrow response is a powerful predictor of outcome in acute lymphoblastic leukemia patients with unfavorable presenting features

  • Effective treatment of unresectable or metastatic hepatoblastoma with Cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group

  • Laser-induced hemostasis in the canine stomach

  • Cytoreduction and Prognosis in Acute Lymphoblastic Leukemia -- The Importance of Early Marrow Response: Report from the Children's Cancer Group

  • Response of Children With High-Risk Acute Lymphoblastic Leukemia Treated With and Without Cranial Irradiation: A Report from the Children's Cancer Group

  • Randomized Phase Ill Trial in Childhood High-Grade Astrocytoma Comparing Vincristine, Lomustine, and Prednisone With the Eight-Drugs-in-1-Day Regimen

  • Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy

  • Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix

  • Temporary Implant in the Management of Carcinoma of the Prostate

  • Endocurietherapy in pediatric oncology

  • Results of a Prospective Randomized Trial Comparing Standard Dose Neuraxis Irradiation (3,600 cGy/20) with Reduced Neuraxis Irradiation (2,340 cGy/13) in Patients with Low-Stage Medulloblastoma: A Combined Children's Cancer Group-Pediatric Oncology Group Study

  • Early Testicular Biopsy in Males with Acute Lymphoblastic Leukemia: Lack of Impact on Subsequent Event-Free Survival

  • Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

  • The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: A report from the Children's Cancer Group

  • Endoscopic argon-ion laser phototherapy of bleeding gastric lesions

  • The effect of pre-irradiation chemotherapy on the delivery of radiation therapy for medulloblastoma and supratentorial PNET. Results of the CCG #921 randomized protocol

  • Cranio-spinal Irradiation for Acute Lymphoblastic Leukemia with CNS Disease at Diagnosis - A Report from the Children's Cancer Group

  • Treatment of High Grade Spinal Cord Astrocytoma of Childhood with "8-in-1" Chemotherapy and Radiotherapy: A Pilot Study of CCG-945

  • Results of a Multi-Institutional Benchmark Test for Cranial CT/MR Image Registration.

  • Gastric hemostasis by laser phototherapy in man

  • Outcome of a phase Ill trial in childhood high-grade astrocytoma comparing vincristine, CCNU and prednisone with the 'in-drugs-in-1-day' regimen. A report of the Children's Cancer Group Trial CCG-945

  • High dose rate brachytherapy in the treatment of carcinoma of the prostate

  • Cranial radiation (CRT) improves event free survival (EFS) for high risk patients with acute lymphoblastic leukemia (ALL) showing a rapid response (RR) to BFM induction chemotherapy

  • Brain Stem Gliomas of Childhood: Outcome after Treatment with 7800 cGy of Hyperfractionated Radiotherapy, A Children's Cancer Group Phase 1/11 Trial

  • The Effects of Initial Central Nervous System (CNS) Status on the Outcome of Children with Acute Lymphoblastic Leukemia (ALL)." Proceeding of the AmericanSociety for Therapeutic Radiology and Oncology, 441 Annual Meeting.

  • Longitudinal Study of Cognitive, Motor, and Behavioral Functioning in Children Diagnosed with Acute Lymphoblastic Leukemia: A Report of Early Findings from the Children's Cancer Group". Acute Leukemias VI Prognostic Factors and Treatment Strategies, Buchner et al. (Eds)

  • Best Doctor in America Radiation Oncology (Woodward-White), 2003 - 200

  • Pediatric Oncology Physician of the Year, Long Beach Memorial Medical Center, 1998

  • Physician of the Quarter, Saddleback Memorial Medical Center, 2nd Quarter, 2001

  • Pediatric Oncology Physician of the Year, Long Beach Memorial Medical Center, 1993

  • Best Doctor in America, Pediatric Radiation Oncology (Woodward-White), 1998 - 199

Locations

Practice

Office24302 Paseo de Valencia Laguna Hills, CA 92653
1
Optum California-Pediatric Sleep Adoption And Development2650 Elm Ave Long Beach, CA 90806
2
Yallapragada S Rao M.D. Inc2650 Elm Ave Ste 201 Long Beach, CA 90806
3

Practice

Long Beach Memorial Pathology Medical Group Inc.2801 Atlantic Ave Long Beach, CA 90806
4

Affiliated Hospitals

  • MemorialCare Saddleback Medical Center

    24451 Health Center Dr
    Laguna Hills, CA 92653
    Recipient of 25
    hospital awards

    America's 250 Best Hospitals Award™ (2025, 2024, 2023)

    Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications

    Patient Safety Excellence Award™ (2025, 2024)

    Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications

    View all awards

    How patients felt about the care they received at this hospital.

    86%
    Patients said they were given information about recovering at home

    2% higher than the national average

    77%
    Patients said that doctors always listened to them and explained things well

    1% higher than the national average

    View all patient feedback
  • MemorialCare Miller Children's & Women's Hospital Long Beach

    2801 Atlantic Ave
    Long Beach, CA 90806
Learn more about how Healthgrades measures Hospital Quality